Novel compounds from Gentiana purpurea L. and their anti-plasmodial evaluation
Lene Sandvik1, Christopher D Goodman2, Karl Egil Malterud1
1Section for Pharmaceutical Chemistry, Department of Pharmacy, University of Oslo, P. O. Box 1068, Blindern, 0316 Oslo, Norway.
Abstract:
Gentiana pupurea L. (Gentianaceae) is an important medicinal plant in Norway and the bitter roots were used against a number of diseases, often related to gastrointestinal ailments and respiratory diseases. Gentian species are reported to be used against malaria in several geographic regions, and in vitro and computational experiments indicate that secoiridoids have an anti-plasmodial effect. Three previously undescribed compounds; the biphenyl secoiridoid glycoside 5''-deoxyamaroswerin, the benzophenone 6''-O-sinapoyl-2,4,3'-trihydroxy-benzophenone-6-O-β-glucopyranoside, and the benzyl benzoate (3-hydroxy-2-methoxybenzyl)-2,3-dihydroxybenzoate, together with eleven other low-molecular compounds were isolated from the 70 % ethanol extract of G. purpurea roots. The structures were elucidated by 1D and 2D NMR methods and high-resolution mass spectrometry. No in vitro anti-plasmodial activity was observed for the 70 % ethanol extract, swertiamarin, sweroside, gentiopicrin, amaroswerin, amarogentin, 5''-deoxyamaroswerin, and amaropanin obtained from G. purpurea.
More Related Videos
08:31Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
Published on: October 11, 2019
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
Related Concept Videos
Antifungal Agents
Anthelminthic Agents
